Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Infections - inflammation - cancer - pregnancy - SLE
secondary amyloidosis (reactive systemic)
causes of increased ESR
CCl4 target
Colon and rectal cancer incidence

2. Larynx (SqCC) - lung (SqCC and SCC) - kidney (renal cell carcinoma) - bladder (transitional cell carcinoma)
CA-125
cigarette smoke target
Pale infarcts
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)

3. Tumor marker: tartrate - resistant acid phosphatase. Hairy cell leukemia (B- cell neoplasm)
Free radical cell damage
TRAP
Acute inflammatory mediators
Neoplasm associated with xeroderma pigmentosum (albinism)

4. Female 13% Male 12%
Colon and rectal cancer incidence
causes of decreased ESR
malignant >1 cell type tumor
Neoplasm associated with xeroderma pigmentosum (albinism)

5. Mature teratoma in women
benign >1 cell type tumor
Barrett's esophagus (chronic GI reflux)
AIDS
Neoplasm associated with Down Syndrome

6. GIST cytokine receptor (oncogene)
erb - B2 gene
c - kit gene
blood vessels malignant tumor
Resolution of inflammation

7. Tumor marker: melanoma - neural tumors - astrocytomas
S-100
benign epithelial tumor
granulomatous disease
bone benign tumor

8. Sarcoma
Neoplasm associated with Down Syndrome
breast cancer incidence/mortality
malignant mesenchyme tumor (general)
Resolution of inflammation

9. Tumor marker: neuroblastoma - lung and gastric cancer
smooth muscle malignant tumor
secondary amyloidosis (reactive systemic)
Bombesin
paraneoplastic effects of renal cell carcinoma - hemangioblastoma

10. Osteoma
bone benign tumor
PSA
Reversible - plasias
blood cell malignant tumors

11. Restoration of normal structure - granulation tissue (vascularized + fibrosis) - abscess (fibrosis + pus) - fistula or scarring (collagen).
Barrett's esophagus (chronic GI reflux)
NF1 gene
Resolution of inflammation
bcl -2 gene

12. Esophagus - stomach
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
nitrosamines (smoked foods) target
CEA
TRAP

13. Neurofibromatosis type 2 22q tumor suppressor (key type 2=22)
ulcerative colitis
CA-19-9
Reversible - plasias
NF2 gene

14. Heart disease
Leading cause of death in the US
blood vessels malignant tumor
fat benign tumor
Primary tumors that met to liver

15. Bladder (transitional cell carcinoma)
Napthalene (aniline) dyes target
Acute inflammatory mediators
BRCA1 gene
skeletal muscle benign tumor

16. Breast cancer 13q tumor suppressor (DNA repair protein)
BRAC2 gene
CA-125
Irreversible - plasias
WT1 gene

17. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
Primary tumors that met to bone
p16 gene
NF1 gene
beta - hCG

18. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor
extrinsic apoptosis
DPC gene
iron poisoning
malignant mesenchyme tumor (general)

19. Malignant melanoma
N- myc gene
dysplastic nevus
blood cell malignant tumors
breast cancer incidence/mortality

20. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
Primary tumors that met to brain
WT1 gene
Resolution of inflammation
TRAP

21. Tumor marker: thyroid medullary carcinoma
smooth muscle benign tumor
abl gene
extrinsic apoptosis
calcitonin

22. Visceral malignancy (stomach - lung - breast - uterus)
Acute inflammatory mediators
acanthosis nigricans (hyperpig and epidermal thickening)
ret gene
Necrosis

23. Osteosarcoma
blood cell malignant tumors
CA-19-9
blood vessels malignant tumor
bone malignant tumor

24. PECAM-1
Rb gene
Leukocyte extravasation: migration
Leukocyte extravasation: diapedesis
CEA

25. Papillary (thyroid) - Serous (ovary) - Meningioma - Mesothelioma
aflatoxin target
fat benign tumor
Where you see Psammoma bodies
NF2 gene

26. Secondary osteosarcoma and fibrosarcoma

27. Gastric adenocacinoma
beta - hCG
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
malignant epithelial tumor
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms

28. Sarcoma - papillary thyroid cancer
malignant >1 cell type tumor
radiation exposure
nitrosamines (smoked foods) target
NF2 gene

29. Adenocarcinoma - papillary carcinoma
benign epithelial tumor
extrinsic apoptosis
malignant epithelial tumor
Colon and rectal cancer incidence

30. Lung - liver - intestine or following reperfusion.
Necrosis
extrinsic apoptosis
Red (hemorrhagic) infarcts
Reversible - plasias

31. Esophageal adenocarcinoma

32. Tumor marker: ovarian - malignant epithelial tumors.
Barrett's esophagus (chronic GI reflux)
benign >1 cell type tumor
CA-125
bone benign tumor

33. Tumor marker: carcinoembryonic Ag Very nonspecific
WT1 gene
CEA
p53 gene
Leukocyte extravasation: diapedesis

34. Leiomyoma
abl gene
skeletal muscle benign tumor
fat malignant tumor
smooth muscle benign tumor

35. Sickle cell (altered shape) - polycythemia (too many) - CHF (unknown)
immunodeficiency states
ras gene
APC gene
causes of decreased ESR

36. Malignant lymphoma
ret gene
cirrosis (alcohol - hepB or C)
immunodeficiency states
Primary tumors that met to brain

37. Hyperuricemia (excess NA turnover)
paraneoplastic effects of leukemias and lymphomas
Colon and rectal cancer incidence
Reversible - plasias
blood cell malignant tumors

38. Rhabdomyoma
skeletal muscle benign tumor
Barrett's esophagus (chronic GI reflux)
Alkylating agents target
Acute inflammatory mediators

39. Liver (hepatocellular carcinoma)
Necrosis
aflatoxin target
WT1 gene
blood vessels malignant tumor

40. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
Prostatic acid phosphatase
arsenic target
erb - B2 gene
DCC gene

41. Liver (angiosarcoma)
smooth muscle benign tumor
secondary amyloidosis (reactive systemic)
vinyl chloride target
DPC gene

42. 32%/18% female
blood vessels malignant tumor
fat malignant tumor
aflatoxin target
breast cancer incidence/mortality

43. Blood (leukemia)
Second - leading cause of death in the US
Reversible - plasias
Alkylating agents target
arsenic target

44. Vascular: ICAM-1 Leukocyte: LFA-1 (integrin)
Leukocyte extravasation: tight binding
Napthalene (aniline) dyes target
DCC gene
dysplastic nevus

45. During embryogenesis - hormone induction and atrophy. Increased mitochondrial permeability and cytochrome c release. Increase Bax (pro - apoptotic) - decreased Bcl -2 (anti - apopotic).
intrinsic apoptosis
DCC gene
breast cancer incidence/mortality
malignant >1 cell type tumor

46. PTH- related peptide - TGF- beta - TNF - IL-1
smooth muscle benign tumor
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
Reversible - plasias
skeletal muscle malignant tumor

47. Skin (SqCC) - liver (angiosarcoma)
arsenic target
nitrosamines (smoked foods) target
Second - leading cause of death in the US
beta - hCG

48. Rhabdomyosarcoma
skeletal muscle malignant tumor
extrinsic apoptosis
Alk - phos
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants

49. Tumor marker: mets to bone - obstructive biliary disease - Paget's
Where you see Psammoma bodies
c - myc gene
BRCA1 gene
Alk - phos

50. MEN type II and III tyrosine kinase (oncogene)
fat malignant tumor
smooth muscle malignant tumor
ret gene
AIDS